Related by context. Frequent words. (Click for all words.) 80 randomized double 77 randomized placebo controlled 74 multicenter 73 placebo controlled 73 double blind placebo 73 randomized controlled 73 multicentre 73 blind randomized placebo 72 blinded placebo controlled 71 prospective randomized 71 randomized Phase III 70 blind randomized 69 randomized 68 dose escalation trial 68 Randomized 67 multicenter clinical 67 Phase 1b clinical 67 randomized controlled clinical 66 Phase 2b study 66 label dose escalation 66 phase IIb 65 randomized Phase 65 dose escalation study 65 blind placebo controlled 65 multicenter study 65 randomized clinical 64 phase IIa 64 Phase 1b 64 Phase Ib 64 single ascending dose 64 randomized #:# 63 Phase 2a clinical 63 Phase IIb 63 Phase IIb clinical 63 Phase III clinical 62 Phase 2b clinical 62 Phase 2a trial 62 Phase 2b trial 62 safety tolerability pharmacokinetics 62 phase 2a 61 Phase 2b 61 dose escalation 61 Phase IIa clinical 61 dose cohorts 61 pivotal Phase III 61 Phase 2a 61 substudy 60 placebo controlled trials 60 multiple ascending dose 60 dose regimens 60 randomized controlled trial 60 Phase IIa 60 Phase IIa trial 60 Phase IIb trial 60 non inferiority 60 Phase III 59 pivotal Phase 59 mg BID 59 confirmatory Phase III 58 SPIRIT III 58 pharmacodynamics 58 Completes Enrollment 58 ZYBRESTAT 58 investigational oral 57 safety tolerability 57 PROPEL 57 clinical trial 57 evaluable patients 56 prospective cohort 56 EORTC 56 Phase III pivotal 56 Initiates Phase 56 TELCYTA 56 laquinimod 56 relapsing remitting multiple sclerosis 56 diabetic neuropathic pain 56 Phase II 56 peginterferon alfa 2b 56 tolerability 55 Efficacy 55 vicriviroc 55 Phase III Trial 55 dabigatran etexilate 55 ocular hypertension 55 HGS ETR1 55 bosentan 55 evaluable 55 lacosamide 55 composite endpoint 55 ACTEMRA 55 unblinded 55 Board DSMB 55 DSMB 54 metastatic renal cell carcinoma 54 FOLFIRI 54 FOLFOX 54 CRx 54 randomized clinical trials 54 PF # [001] 54 Taxotere ® 54 tolerated dose MTD